- <![CDATA[Dr Mauro on the Significance of Alternative TKI Formulations in CML]]><![CDATA[Michael Mauro, MD, details the FDA approval of the small-molecule formulation of dasatinib and other alternate TKI formulations in chronic myeloid leukemia.]]>onclive · 2mo ago↗ source
- <![CDATA[Women With Bladder Cancer Face Diagnostic Delays as Symptoms Mimic UTIs, Experts Warn]]><![CDATA[Timothy N. Clinton, MD, and Stephanie A. Berg, DO, discuss gender differences in bladder cancer during Bladder Cancer Awareness Month.]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Olawaiye on the FDA Approval of Relacorilant Plus Nab-Paclitaxel in PROC]]><![CDATA[Alexander B. Olawaiye, MD, discusses the clinical significance of the FDA approval of relacorilant plus nab-paclitaxel in PROC.]]>